A conversation with patients about medications after a stroke

Not Applicable

Completed

• Conditions: Transient Ischemic Attack; Stroke; Medication adherence; Adverse Drug Events; Stroke - Ischaemic; Public Health - Health promotion/education; Stroke - Haemorrhagic

• Registration Number: ACTRN12615000888561
• Lead Sponsor: Judith Coombes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-25
• Study Completion: 2020-05-13
• Last Update Posted: 16 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

aged 18 years or older,
have been admitted under the Medical Stroke Unit” or Medical Admission and Planning Unit at Princess Alexandra Hospital, with a principal diagnosis of Stroke or TIA,
planned to be discharged to their home.
patient manages their medication,
patient has a Mental Status Questionnaire (MSQ) score of 10/10 on the Neurological Observation Chart
the patient is able to provide consent.

Exclusion Criteria

Those patients planned for discharge to a residential care facility (eg a nursing or residential care home) where a staff member is responsible for the patients’ medication administration
those unable to complete the questionnaire (even) with assistance (this may be due to language difficulties or cognitive impairment)
those who do not wish to take part.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is adherence measured by the proportion of days covered (PDC) over the three months after discharge, using prescription refill data (obtained from the pharmaceutical benefits scheme (PBS)) for the combination of all three classes of medications (antithrombotic, antihypertensive and lipid lowering medications)prescribed. [3 months after discharge]